糞鈣衛蛋白檢測市場：依檢測類型、依適應症、依最終用戶、地區

全球糞便鈣衛蛋白檢測市場預計將從 2023 年的 1.228 億美元增加到 2030 年的 2.766 億美元，2023-2030 年預測期間複合年成長率為 12.3%。

圖 1. 2023 年糞鈣衛蛋白檢測的全球市場佔有率(%)（依地區）

消化器官系統發炎是由一種稱為發炎性腸道疾病（IBD）的慢性疾病引起的。腸道中的白血球在糞便中釋放一種稱為鈣衛蛋白的蛋白質。它在 IBD 患者中升高，使其成為識別和追蹤疾病的有用生物標記。

市場動態：

胃腸道疾病盛行率的增加、認知的提高和早期檢測、非侵入性和便捷的檢測預計將在預測期內推動全球糞便鈣衛蛋白檢測市場的成長。此外，醫療保健提供者預計將擴大採用糞鈣衛蛋白測試市場也將在預測期內促進全球糞便鈣衛蛋白測試市場的成長。新興市場、即時檢測、家庭檢測套組以及與數位健康技術選項的整合預計將為預測期內全球糞便鈣衛蛋白檢測市場提供成長機會。

然而，有限的報銷範圍、成本考慮、檢測結果的可變性、有限的意識和醫生知識預計將阻礙預測期內全球糞便鈣衛蛋白檢測市場的成長。

本研究的主要特點

• 該報告詳細分析了糞便鈣衛蛋白檢測的全球市場，並提供了以2022年為基準年的預測期（2023-2030年）的市場規模和複合年成長率。
• 它還闡明了各個區隔市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
• 它根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球糞鈣衛蛋白測試市場的主要企業。
• 該報告的見解使行銷人員和經營團隊負責人就未來的產品發布、類型升級、市場擴張和行銷策略做出資訊的決策。
• 本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 相關人員可以透過用於分析全球糞便鈣衛蛋白測試市場的各種策略矩陣來促進他們的決策。

第1章 研究目的與前提

• 研究目標
• 假設
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

• 市場動態
  • 胃腸道疾病盛行率增加
  • 糞便鈣衛蛋白檢測的報銷範圍可能有限
  • 與數位健康科技整合
• 影響分析
• 主要亮點
• 監管場景
• 產品發布/核准
• PEST分析
• 波特的分析
• 併購場景

第4章全球糞鈣衛蛋白檢測市場 - 冠狀冠狀病毒(COVID-19) 大流行的影響

• 新型冠狀病毒感染疾病（COVID-19）的流行病學
• 供需面分析
• 經濟影響

第5章全球糞便鈣衛蛋白檢測市場，依檢測類型，2018-2030

• 酵素結合免疫吸附測定法 (ELISA)
• 酵素氟化物免疫檢測
• 定量層析法

第6章 2018-2030 年全球糞鈣衛蛋白檢測市場（依適應症）

• 發炎性腸道疾病（IBD）的診斷
• 大腸直腸癌
• 乳糜瀉
• 其他

第 7 章全球糞鈣衛蛋白檢測市場，依最終用戶分類，2018-2030 年

• 醫院
• 診斷實驗室
• 學術研究所
• 其他

第8章2018-2030年全球糞鈣衛蛋白檢測市場（依地區）

• 北美洲
• 美國
• 加拿大
• 歐洲
• 德國
• 英國
• 法國
• 西班牙
• 義大利
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 中國
• 印度
• 日本
• 澳洲
• 韓國
• ASEAN
• 其他亞太地區
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中東和非洲
• 海灣合作理事會國家
• 以色列
• 其他中東地區
• 非洲
• 南非
• 北非
• 中部非洲

第9章競爭形勢

• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd.
• Becton, Dickinson and Company
• Abbexa Limited
• Bioserv Diagnostics Gmbh
• Epitope Diagnostics, Inc.
• LifeSpan BioSciences, Inc.
• RayBiotech, Inc.
• ALPCO

第10章

• 調查方法
• 關於出版商

The global fecal calprotectin test market is projected to reach US$ 276.6 million by 2030, from US$ 122.8 million in 2023, at a CAGR of 12.3% during the forecast period 2023-2030.

Figure 1. Global Fecal Calprotectin Test Market Share (%), by Region, 2023

Inflammation of the digestive system is brought on by the chronic illness of Inflammatory bowel disease (IBD). White blood cells in the intestines release a protein called fecal calprotectin. It is high in IBD patients, making it a helpful biomarker for identifying and tracking the condition.

Market Dynamics:

The increasing prevalence of gastrointestinal disorders, growing awareness and early detection, and non-invasive and convenient testing are anticipated to drive growth of the global fecal calprotectin test market over the forecast period. Moreover, increasing adoption by healthcare providers is also expected to boost growth of the global fecal calprotectin test market over the forecast period. Emerging markets, point-of-care testing, home-based testing kits, and integration with digital health technology options are expected to create growth opportunities for the global fecal calprotectin test market during the forecast period.

However, limited reimbursement coverage, cost considerations, variability in test results, and limited awareness and physician knowledge are expected to hamper growth of the global fecal calprotectin test market over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global fecal calprotectin test market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global fecal calprotectin test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbexa Limited, Bioserv Diagnostics Gmbh, Epitope Diagnostics, Inc., LifeSpan BioSciences, Inc., RayBiotech, Inc., ALPCO
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global fecal calprotectin test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders have ease in decision-making through various strategy matrices used in analyzing the would global fecal calprotectin test market

Detailed Segmentation:

• By Assay Type:
  • Enzyme Linked Immunosorbent Assay (ELISA)
  • Enzyme Fluoroimmunoassay
  • Quantitative Immune-Chromatography
• By Indication:
  • Inflammatory Bowel Disease (IBD) Diagnosis
  • Colorectal Cancer
  • Celiac Disease
  • Others
• By End User:
  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Others
• By Region:
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East
  • Africa
• Top companies in Fecal Calprotectin Test Market
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Abbexa Limited
  • Bioserv Diagnostics Gmbh
  • Epitope Diagnostics, Inc.
  • LifeSpan BioSciences, Inc.
  • RayBiotech, Inc.
  • ALPCO

Table of Content

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market global fecal calprotectin test, By Assay Type
  • Market global fecal calprotectin test, By Indication
  • Market global fecal calprotectin test, By End User
  • Market global fecal calprotectin test, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing prevalence of gastrointestinal disorders
  • Rreimbursement coverage for Fecal Calprotectin Tests may be limited
  • Integration with digital health technologies
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Fecal Calprotectin Test Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Fecal Calprotectin Test Market, By Assay Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Enzyme Linked Immunosorbent Assay (ELISA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Enzyme Fluoroimmunoassay
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Quantitative Immune-Chromatography
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Global Fecal Calprotectin Test Market, By Indication, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Inflammatory Bowel Disease (IBD) Diagnosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
• Colorectal Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
• Celiac Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

7. Global Fecal Calprotectin Test Market, By End User, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

8. Global Fecal Calprotectin Test Market, By Region, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2019 -2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Assay Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Assay Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• Germany
• U.K.
• France
• Spain
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Assay Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Assay Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Assay Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Assay Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Mn)
• South Africa
• North Africa
• Central Africa

9. Competitive Landscape

• Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• F. Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Abbexa Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bioserv Diagnostics Gmbh
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Epitope Diagnostics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• LifeSpan BioSciences, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• RayBiotech, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• ALPCO
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us